Introduction Integration of management of tuberculosis (TB) and HIV with prevention and treatment of non-communicable diseases (NCDs) is a global priority. However, delivering the full spectrum of HIV ...

Despite decades of experience, advanced health systems, and deep medical knowledge, the WHO European region is still at risk from the global epidemic of tuberculosis. There are at least three pressing ...

AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...

CureTB referrals showed higher TB treatment completion when patients were linked to care quickly after relocation.

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

TB disease affects Asian persons more than others.‎ In 2023, TB disease was reported among 2,887 non-Hispanic Asian persons in the United States. This accounts for 30.0% of all people reported with TB ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

More daily smokers with tuberculosis receiving a mobile health intervention achieved self-reported and biochemically verified ...

Shorter all-oral regimens can improve treatment adherence, reduce patient morbidity, and enable faster return to normal life, while also lowering the burden on the health system ...

Malaysia reported 10 new tuberculosis (TB) clusters in 2026 as at Feb 7, and some health experts have advised those ...

ICMR study finds shorter all-oral regimens for drug-resistant TB are cost-effective and improve health outcomes in India.